Related Experiment Videos

Restriction of major surface protein 2 (MSP2) variants during tick transmission of the ehrlichia Anaplasma marginale

F R Rurangirwa1, D Stiller, D M French

  • 1Program in Vector-Borne Diseases, Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164-7040, USA.

Insights

Anaplasma marginale variant types expressed in tick salivary glands predict disease. This finding supports developing MSP2 vaccines against cattle ehrlichial pathogen infections.

Area of Science:

  • Veterinary Microbiology
  • Tick-borne Diseases
  • Molecular Epidemiology

Background:

  • Anaplasma marginale causes persistent ehrlichial infections in cattle.
  • Infection is marked by rickettsemic cycles with emergence of new A. marginale variant types.
  • Antigenic variation of MSP2 proteins contributes to pathogen diversity.

Purpose of the Study:

  • To investigate the repertoire of A. marginale variant types expressed in tick salivary glands.
  • To determine if tick-expressed variants predict those causing acute rickettsemia upon transmission.
  • To evaluate the potential for MSP2-based vaccines.

Main Methods:

  • Sequence analysis of msp2 transcripts from tick salivary glands.
  • Comparison of tick-expressed variants with those in infected cattle blood.
  • Monitoring rickettsemia and variant types following experimental tick transmission.

Main Results:

  • A restricted repertoire of A. marginale variant types (SGV1 and SGV2) was identified in tick salivary glands.
  • These SGV1 and SGV2 variants were consistently expressed in ticks, irrespective of cattle blood variants at acquisition.
  • Tick transmission resulted in acute rickettsemia solely composed of SGV1 and SGV2 variants.

Conclusions:

  • A. marginale variant type expression in tick salivary glands predicts the variants responsible for acute rickettsemia.
  • This restriction contrasts with the diversity observed in persistently infected cattle.
  • Targeting MSP2 offers a promising strategy for vaccines against tick-transmitted anaplasmosis.

Related Concept Videos